Delcath Systems Inc (DCTH)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Gerard J. Michel
Employees:
60
1633 BROADWAY, SUITE 22C, NEW YORK, NY 10019
(212) 489-2100

Delcath Systems, Inc. focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver.

Data derived from most recent annual or quarterly report
Market Cap 42.774 Million Shares Outstanding15.276 Million Avg 30-day Volume 474.078 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.14
Price to Revenue33.4314 Debt to Equity0.4028 EBITDA-33.731 Million
Price to Book Value2.9267 Operating Margin-1604.9907999999998 Enterprise Value41.789 Million
Current Ratio3.299 EPS Growth0.086 Quick Ratio2.91
1 Yr BETA 0.0129 52-week High/Low 7.99 / 2.25 Profit Margin-2080.1294
Operating Cash Flow Growth-28.84 Free Cash Flow to Firm (FCFF) TTM -21.495 Million Free Cash Flow to Equity (FCFE) TTM-17.324 Million
Altman Z-Score-14.1916
View SEC Filings from DCTH instead.

View recent insider trading info

Delcath Systems Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding DCTH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DCTH

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-11-21 by ROSALIND ADVISORS, INC.
  • 4: filed on 2023-11-21 by PENNELL SANDRA
  • 4: filed on 2023-11-20 by VUKOVIC VOJO
  • 4: filed on 2023-11-20 by HOFFMAN DAVID L.
  • 4: filed on 2023-10-17 by PURPURA JOHN
  • 4: filed on 2023-08-23 by SYLVESTER JOHN RICHARD
  • 4: filed on 2023-08-21 by MICHEL GERARD J
  • 4: filed on 2023-06-22 by SALAMON STEVEN A J
  • 4: filed on 2023-06-22 by Aharon Gil
  • 4: filed on 2023-06-22 by SYLVESTER JOHN RICHARD

    • Events (8k)

  • 8-K: filed on 2023-11-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-06:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-15:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-04:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-06-22:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-13:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-30:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    244.5 Thousand total shares from 5 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ROSALIND ADVISORS, INC.

    SALAMON STEVEN A J

    AHARON GIL

    • Director
    		 1,038,828 2023-11-17 5

    PENNELL SANDRA SVP OF FINANCE, PFO AND PAO

    • Officer
    		 30,000 2023-11-17 3

    VUKOVIC VOJO CHIEF MEDICAL OFFICER

    • Officer
    		 60,000 2023-11-16 2

    HOFFMAN DAVID L. SEE REMARKS

    • Officer
    		 40,000 2023-11-16 2

    PURPURA JOHN CHIEF OPERATING OFFICER

    • Officer
    		 41,526 2023-10-13 2

    SYLVESTER JOHN RICHARD

    • Director
    		 10,550 2023-08-21 2

    MICHEL GERARD J CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 228,345 2023-08-18 4

    STOLL ROGER G PHD

    • Director
    		 0 2023-06-12 1

    CZEREPAK ELIZABETH

    • Director
    		 0 2023-06-12 1

    SALAMON STEVEN A J

    • Director
    		 0 2023-06-12 3

    AHARON GIL

    • Director
    		 0 2023-06-12 2

    JOHN JOHNNY SEE REMARKS

    • Officer
    		 0 2023-06-12 1

    MUIR KEVIN SEE REMARKS

    • Officer
    		 0 2023-06-12 1

    ROSALIND ADVISORS, INC.

    • Director
    		 459,315 2022-12-14 5

    DIAS ANTHONY VICE PRESIDENT OF FINANCE

    • Officer
    		 0 2022-05-04 0

    PADULA CHRISTINE SEE REMARKS

    • Officer
    		 30,000 2021-09-01 0

    RUECKERT WILLIAM DODGE

    • Director
    		 6,014 2020-05-08 0

    TAGLIETTI MARCO

    • Director
    		 6,001 2020-05-08 0

    KECK BARBRA SEE REMARKS

    • Officer
    		 12,851 2020-05-06 0

    SIMPSON JENNIFER K. PRESIDENT AND CEO

    • Officer
    • Director
    		 25,021 2020-05-06 0

    PEDDER SIMON

    • Director
    		 0 2019-02-01 0

    PHILIPS LAURA A

    • Director
    		 205,299 2015-07-22 0

    LANGER DENNIS

    • Director
    		 20,000 2015-06-10 0

    KOPLEWICZ HAROLD S

    • Director
    		 45,052 2015-06-10 0

    WATSON DOUGLAS G

    • Director
    		 7,938 2014-07-10 0

    LEUNG GABRIEL

    • Director
    		 21,485 2014-07-07 0

    KONIDARIS TASOS

    • Director
    		 11,678 2014-07-07 0

    BREGE LAURA

    • Director
    		 11,678 2014-07-07 0

    GRAHAM PETER J EVP; GENERAL COUNSEL

    • Officer
    		 0 2013-11-14 0

    MIAO GRAHAM G INTERIM CO-CEO & PRES.EVP, CFO

    • Officer
    		 0 2013-11-14 0

    APPLING WILLIAM M EVP, R&D AND GLOBAL OPERATIONS

    • Officer
    		 0 2013-07-15 0

    GAGO AGUSTIN V EVP GLOBAL SALES & MARKETING

    • Officer
    		 0 2013-03-11 0

    HOBBS EAMONN P PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2013-03-11 0

    MAPES HAROLD EXEC. V. P., GLOBAL OPERATIONS

    • Officer
    		 0 2013-03-11 0

    KANDARPA KRISHNA EXEC. V.P., CHIEF MEDICAL OFF.

    • Officer
    		 0 2013-03-11 0

    LADD ROBERT

    • Director
    		 700,828 2012-06-15 0

    MCDONALD DAVID CHIEF FINANCIAL OFFICER

    • Officer
    		 47,706 2011-03-10 0

    CONTAG PAMELA REILLY

    • Director
    		 8,507 2010-12-01 0

    TANEY RICHARD

    • Director
    		 211,485 2009-12-10 0

    RIFKIN JASON ANDREW SR. VP CLINICAL OPER. & SECY

    • Officer
    		 0 2009-10-12 0

    LEWIS JONATHAN

    • Director
    		 10,000 2008-06-30 0

    FEINSTEIN PAUL M CHIEF FINANCIAL OFFICER

    • Officer
    		 35,000 2007-11-30 0

    HERSCHKOWITZ SAMUEL /FA/ CHIEF OPERATING OFFICER

    • Officer
    • Director
    		 160,375 2007-05-25 0

    ISDANER DANIEL

    • Director
    		 478,893 2007-04-16 0

    CORIGLIANO MARK

    • Director
    		 660,626 2007-04-16 0

    KOLY M S /FA/

    • Director
    		 1,450,710 2007-01-26 0

    NEVINS VICTOR

    • Director
    		 180,007 2006-10-12 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    PENNELL SANDRA - Officer SVP OF FINANCE, PFO AND PAO

    		2023-11-21 07:42:49 -0500 2023-11-17 P 30,000 $2.43 a 30,000 direct -2.3649 -5.4054 1.0135 3 -5.4054 6

    ROSALIND ADVISORS, INC. - Director by rosalind advisors, inc., the advisor to the rosalind funds

    SALAMON STEVEN A J - Director by rosalind advisors, inc., the advisor to the rosalind funds

    AHARON GIL - Director by rosalind advisors, inc., the advisor to the rosalind funds

    		2023-11-21 11:07:33 -0500 2023-11-17 P 100,000 $2.40 a 1,038,828 indirect -2.3649 -5.4054 1.0135 3 -5.4054 6

    HOFFMAN DAVID L. - Officer SEE REMARKS

    		2023-11-20 16:20:28 -0500 2023-11-16 P 40,000 $2.48 a 40,000 direct -2.3649 -5.4054 1.0135 3 -5.4054 6

    VUKOVIC VOJO - Officer CHIEF MEDICAL OFFICER

    		2023-11-20 16:22:23 -0500 2023-11-16 P 60,000 $2.48 a 60,000 direct -2.3649 -5.4054 1.0135 3 -5.4054 6

    PURPURA JOHN - Officer CHIEF OPERATING OFFICER

    		2023-10-17 16:53:31 -0400 2023-10-13 P 14,505 $3.44 a 41,526 direct -2.3684 -9.4737 0.0 1 -9.4737 6

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    DELCATH SYSTEMS INC DCTH 2023-11-30 20:16:16 UTC 0.911 4.409 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 19:45:03 UTC 0.911 4.409 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 19:15:04 UTC 0.911 4.409 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 18:45:04 UTC 0.911 4.409 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 18:15:04 UTC 0.911 4.409 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 17:45:04 UTC 0.911 4.409 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 17:15:04 UTC 0.911 4.409 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 16:45:03 UTC 0.903 4.417 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 16:15:04 UTC 0.903 4.417 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 15:45:04 UTC 0.903 4.417 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 15:15:04 UTC 0.903 4.417 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 14:45:04 UTC 0.903 4.417 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 14:15:04 UTC 0.903 4.417 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 13:45:04 UTC 0.8892 4.4308 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 13:15:04 UTC 0.8892 4.4308 950000
    DELCATH SYSTEMS INC DCTH 2023-11-30 12:45:03 UTC 0.8892 4.4308 900000
    DELCATH SYSTEMS INC DCTH 2023-11-29 22:15:05 UTC 0.8892 4.4308 1000000
    DELCATH SYSTEMS INC DCTH 2023-11-29 21:45:04 UTC 0.8892 4.4308 1000000
    DELCATH SYSTEMS INC DCTH 2023-11-29 21:15:05 UTC 0.8892 4.4308 1000000
    DELCATH SYSTEMS INC DCTH 2023-11-29 20:45:04 UTC 0.8892 4.4308 1000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments